None listed
Conditions
Interventions
Medical Device : In the experimental group, LiCOL GOLD®—a soft-tissue augmentation agent whose active component is cross-linked dextran microparticles suspended in hydroxypropyl methylcellulose—was ad
Sponsors
Kangdong Sacred Heart Hospital
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Premenopausal adult women aged 21–55 years with a VLQ score =3 during intercourse were eligible. Only women who had undergone at least one vaginal delivery at least one year before enrollment were included. All participants agreed to refrain from any urological or gynecological treatment that could affect the study during the trial period.
Exclusion criteria
Exclusion criteria: Subjects were excluded if they had a history of psychiatric disorder; congenital or acquired vaginal malformation; current use of anticoagulants within four weeks before enrollment; concomitant treatment for vaginal laxity at another institution (e.g., RF therapy); pelvic organ prolapse of stage III or higher; an untreated sexually transmitted infection; or were less than one year postpartum.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the proportion in whom the VLQ (Vaginal Laxity Questionnaire) score improved to =5 | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in vaginal squeeze pressure | — |
Countries
Korea, Republic of
Contacts
Public ContactKyungtae Ko
Kangdong Sacred Heart Hospital
Outcome results
None listed